These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12369987)

  • 1. Modifying TNFalpha for therapeutic use: a perspective on the TNF receptor system.
    Hasegawa A; Takasaki W; Greene MI; Murali R
    Mini Rev Med Chem; 2001 May; 1(1):5-16. PubMed ID: 12369987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for tumor necrosis factor blockade with the therapeutic antibody golimumab.
    Ono M; Horita S; Sato Y; Nomura Y; Iwata S; Nomura N
    Protein Sci; 2018 Jun; 27(6):1038-1046. PubMed ID: 29575262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insertion of foreign T cell epitopes in human tumor necrosis factor alpha with minimal effect on protein structure and biological activity.
    Nielsen FS; Sauer J; Bäcklund J; Voldborg B; Gregorius K; Mouritsen S; Bratt T
    J Biol Chem; 2004 Aug; 279(32):33593-600. PubMed ID: 15173183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Biology of the TNFα Antagonists Used in the Treatment of Rheumatoid Arthritis.
    Lim H; Lee SH; Lee HT; Lee JU; Son JY; Shin W; Heo YS
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based design and characterization of exocyclic peptidomimetics that inhibit TNF alpha binding to its receptor.
    Takasaki W; Kajino Y; Kajino K; Murali R; Greene MI
    Nat Biotechnol; 1997 Nov; 15(12):1266-70. PubMed ID: 9359109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an in vivo orally active dual-binding protein-protein interaction inhibitor targeting TNFα through combined in silico/in vitro/in vivo screening.
    Mouhsine H; Guillemain H; Moreau G; Fourati N; Zerrouki C; Baron B; Desallais L; Gizzi P; Ben Nasr N; Perrier J; Ratsimandresy R; Spadoni JL; Do H; England P; Montes M; Zagury JF
    Sci Rep; 2017 Jun; 7(1):3424. PubMed ID: 28611375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-TNF-α Drugs Differently Affect the TNFα-sTNFR System and Monocyte Subsets in Patients with Psoriasis.
    Gibellini L; De Biasi S; Bianchini E; Bartolomeo R; Fabiano A; Manfredini M; Ferrari F; Albertini G; Trenti T; Nasi M; Pinti M; Iannone A; Salvarani C; Cossarizza A; Pellacani G
    PLoS One; 2016; 11(12):e0167757. PubMed ID: 27936119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor-alpha antagonists: differential clinical effects by different biotechnological molecules.
    Licastro F; Chiappelli M; Ianni M; Porcellini E
    Int J Immunopathol Pharmacol; 2009; 22(3):567-72. PubMed ID: 19822073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-TNFalpha therapy in systemic autoimmune and/or inflammatory diseases].
    Régent A; Mouthon L
    Presse Med; 2009 May; 38(5):761-73. PubMed ID: 19349142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumab.
    Armuzzi A; Lionetti P; Blandizzi C; Caporali R; Chimenti S; Cimino L; Gionchetti P; Girolomoni G; Lapadula G; Marchesoni A; Marcellusi A; Mennini FS; Salvarani C; Cimaz R
    Int J Immunopathol Pharmacol; 2014; 27(1 Suppl):11-32. PubMed ID: 24774504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of tumor necrosis factor-alpha (TNF-alpha)/TNF-alpha receptor binding by structural analogues of suramin.
    Mancini F; Toro CM; Mabilia M; Giannangeli M; Pinza M; Milanese C
    Biochem Pharmacol; 1999 Sep; 58(5):851-9. PubMed ID: 10449196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A trivalent TNF-R2 as a new tumor necrosis factor alpha-blocking molecule.
    Contreras MA; Macaya L; Manrique V; Camacho F; González A; Montesinos R; Toledo JR; Sánchez O
    Proteins; 2021 Nov; 89(11):1557-1564. PubMed ID: 34250652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The TNF and TNF receptor superfamilies: integrating mammalian biology.
    Locksley RM; Killeen N; Lenardo MJ
    Cell; 2001 Feb; 104(4):487-501. PubMed ID: 11239407
    [No Abstract]   [Full Text] [Related]  

  • 14. TNF in the inflammatory response.
    Männel DN; Echtenacher B
    Chem Immunol; 2000; 74():141-61. PubMed ID: 10608086
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor necrosis factor inhibitors: following best practice.
    White B
    Manag Care; 2005 May; 14(5 Suppl):17-23. PubMed ID: 15962833
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of Orally Efficacious Allosteric Inhibitors of TNFα via Fragment-Based Drug Design.
    Dietrich JD; Longenecker KL; Wilson NS; Goess C; Panchal SC; Swann SL; Petros AM; Hobson AD; Ihle D; Song D; Richardson P; Comess KM; Cox PB; Dombrowski A; Sarris K; Donnelly-Roberts DL; Duignan DB; Gomtsyan A; Jung P; Krueger AC; Mathieu S; McClure A; Stoll VS; Wetter J; Mankovich JA; Hajduk PJ; Vasudevan A; Stoffel RH; Sun C
    J Med Chem; 2021 Jan; 64(1):417-429. PubMed ID: 33378180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Basis for the Neutralization of Tumor Necrosis Factor α by Certolizumab Pegol in the Treatment of Inflammatory Autoimmune Diseases.
    Lee JU; Shin W; Son JY; Yoo KY; Heo YS
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28124979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recombinant proteins or monoclonal antibodies: comparative properties and interest in rheumatoid arthritis].
    Sibilia J
    Med Sci (Paris); 2009 Dec; 25(12):1033-8. PubMed ID: 20035675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of highly potent TNFα inhibitors using virtual screen.
    Shen Q; Chen J; Wang Q; Deng X; Liu Y; Lai L
    Eur J Med Chem; 2014 Oct; 85():119-26. PubMed ID: 25078315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential biological and clinical significance of the soluble tumor necrosis factor receptors.
    Aderka D
    Cytokine Growth Factor Rev; 1996 Oct; 7(3):231-40. PubMed ID: 8971478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.